Study of FTY720 in Patients With Uveitis

A Multicenter, Randomized, Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of FTY720 in Patients With Acute, Noninfectious Intermediate, Posterior and Pan Uveitis

This study will assess the safety, tolerability, and efficacy of FTY720 in patients with acute, noninfectious intermediate, posterior and pan uveitis

Inclusion Criteria:

• Acute noninfectious posterior, intermediate, or pan uveitis
• Vitreous haze score of 1+ or more in the study eye at screening and baseline visits

Exclusion Criteria:

• Vaso-occlusive vasculitis involving the retinal macula
• Behçet's uveitis
• Patients requiring corticosteroid or another systemic immunosuppressive medication for any other disease (e.g., asthma or some other autoimmune disease) that would contraindicate tapering (topical steroids permitted)
• Other protocol defined inclusions and/or exclusions may apply.